Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD4+ T-cell receptors specific for House Dust Mite (HDM)-derived peptides are specialized immune receptors that play a central role in the development and maintenance of HDM-induced allergic diseases, including asthma and allergic rhinitis. These receptors recognize allergenic peptides derived from mite proteins, such as Der p 1 and Der p 2, when presented by Major Histocompatibility Complex (MHC) class II molecules on antigen-presenting cells (Wambre et al., 2012). In sensitized individuals, the interaction between the TCR and the HDM peptide-MHC complex triggers the activation of Th2-polarized CD4+ T cells, which drive the allergic inflammatory cascade through the production of cytokines like IL-4, IL-5, and IL-13 (Galli et al., 2008). Therapeutic interventions, such as allergen-specific immunotherapy (AIT), utilize HDM extracts or synthetic peptides to target these TCRs, aiming to induce immunological tolerance or immune deviation toward a regulatory T-cell (Treg) or Th1 phenotype (Akdis & Akdis, 2014). By modulating the activity of these specific T-cell populations, clinicians can reduce allergic symptoms and prevent the progression of respiratory disease. Monitoring the dynamics of HDM-specific TCR repertoires and associated biomarkers is increasingly used to evaluate patient response to immunotherapy (Cunningham et al., 2021).
Induction of immune tolerance through T-cell anergy, deletion, or immune deviation from a Th2 to a Th1/Treg response.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD4+ T-cell receptor specific for House Dust Mite-derived peptides (HDM-specific TCR).